TADF-based NIR-II semiconducting polymer dots for in vivo 3D bone imaging.
Keng-Fang HsuShih-Po SuHsiu-Feng LuMing-Ho LiuYuan Jay ChangYi-Jang LeeHuihua Kenny ChiangChao-Ping HsuChin-Wei LuYang-Hsiang ChanPublished in: Chemical science (2022)
Intraoperative fluorescence imaging in the second near-infrared (NIR-II) region heralds a new era in image-guided surgery since the success in the first-in-human liver-tumor surgery guided by NIR-II fluorescence. Limited by the conventional small organic NIR dyes such as FDA-approved indocyanine green with suboptimal NIR-II fluorescence and non-targeting ability, the resulting shallow penetration depth and high false positive diagnostic values have been challenging. Described here is the design of NIR-II emissive semiconducting polymer dots (Pdots) incorporated with thermally activated delayed fluorescence (TADF) moieties to exhibit emission maxima of 1064-1100 nm and fluorescence quantum yields of 0.40-1.58% in aqueous solutions. To further understand how the TADF units affect the molecular packing and the resulting optical properties of Pdots, in-depth and thorough density-functional theory calculations were carried out to better understand the underlying mechanisms. We then applied these Pdots for in vivo 3D bone imaging in mice. This work provides a direction for future designs of NIR-II Pdots and holds promising applications for bone-related diseases.
Keyphrases
- fluorescence imaging
- photodynamic therapy
- fluorescent probe
- density functional theory
- drug release
- single molecule
- molecular dynamics
- minimally invasive
- energy transfer
- bone mineral density
- optical coherence tomography
- soft tissue
- mass spectrometry
- postmenopausal women
- metabolic syndrome
- surgical site infection
- adipose tissue
- coronary artery disease
- molecular dynamics simulations
- percutaneous coronary intervention
- quantum dots
- atrial fibrillation
- body composition
- solid phase extraction